Skip to main content

Table 1 Demographics and clinical characteristics of total cohort and study population.

From: Treatment with pollen allergen immunotherapy improves health-related quality of life in children and adolescents: a three-year follow-up-study

 

Total population n = 246

Study population n = 158

Sex: boy n (%)

154 (63)

102 (65)

Age at start mean, SD (range)

11, 2.8 (5–17)

11, 2.7 (5–16)

Allergen treatment n (%)

 Birch

174 (71)

122 (77)

 Grass

47 (19)

12 (8)

 Both grass and birch

24 (10)

24 (15)

SYMPTOMS at start n (%)

 Rhinoconjunctivitis

68 (28)

41 (26)

 Asthma and rhinoconjunctivitis

176 (71)

117 (74)